BUILDING A NEW CLASS OF PEPTIDE DRUGS

Designed Biologics Inc is dedicated to the development of small peptides (30 to 75 amino acids) with designed targeting properties. Combining molecular interaction analytics with high performance computing, Designed Biologics creates new classes of small proteins for the treatment of human diseases and diagnostics.

Our new smart biologics target traditionally undruggable targets and focus on alternative binding characteristics to engage novel disease fighting mechanisms.